Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« The Referee Reports Are In | Main | The Health Care Bill: A Therapeutic Rant »

March 19, 2010

A Bit More Garage Biotech

Email This Entry

Posted by Derek

Here's the sort of thing we'll be seeing more and more of - on the whole, I think it's a good development, but it's certainly possible that one's mileage could vary:

Ginkgo’s BioBrick Assembly Kit includes the reagents for constructing BioBrick parts, which are nucleic acid sequences that encode a specific biological function and adhere to the BioBrick assembly standard. The kit, which includes the instructions for putting those parts together, sells for $235 through the New England BioLabs, an Ipswich, MA-based supplier of reagents for the life sciences industry.

Shetty didn’t release any specific sales figures for the kit, but said its users include students, researchers, and industrial companies. The kit was also intended to be used in the International Genetically Engineered Machine competition (iGEM), in Cambridge, MA. The undergraduate contest, co-launched by Knight, challenges students teams to use the biological parts to build systems and operate them in living cells.

Comments (4) + TrackBacks (0) | Category: Biological News


COMMENTS

1. A "Synthetic Biologist" on March 19, 2010 11:32 AM writes...

Aside from the few labs that developed them, I've heard nothing but bad things about BioBricks. I see the value of the idea behind them, but apparently they're nearly unusable in practice.

And I don't think that Ginkgo quite qualifies as "garage biotech" - they have some pretty sweet lab space right on the Boston waterfront, and some fairly prominent researchers (Drew Endy, Tom Knight) behind the company. I'm just not so sure about their business model...

Permalink to Comment

2. get a life on March 19, 2010 9:18 PM writes...

You mean garbage bioech....

Permalink to Comment

3. Rich Rostrom on March 20, 2010 1:00 PM writes...

ASB: I think the point is not that Ginkgo is "garage biotech", but that BioBricks (if they work) would allow people to do "garage biotech".

Or at the very least, make biotech a lot more accessible on a low budget with minimal facilities.

Permalink to Comment

4. A "Synthetic Biologist" on March 20, 2010 3:44 PM writes...

Rich: Ah, I think you're right. I wasn't thinking about it that way, but that makes much more sense.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
More on the Science Chemogenomic Signatures Paper
Biology Maybe Right, Chemistry Ridiculously Wrong
Encoded Libraries Versus a Protein-Protein Interaction
The State of Alzheimer's Research, 2014
AstraZeneca's Cambridge Move
A Call For Better Mouse Studies
Biotech Boom, Biotech Bust?
Can You Patent A Natural Product? Prepare For a Different Answer